QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

INNV

QT75InnovAge Holding Corp.
NASDAQ·Healthcare·Medical - Care Facilities·USA
Latest market price
8.97
-0.18-1.97%
OverviewShort InterestFilings
INNVQT75InnovAge Holding Corp.·NASDAQ
OverviewShort InterestFilings
8.97-1.97%
TA
Loading chart...
Screen all →
HCA-3.35%$375.17THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59EHC+0.14%$98.03ENSG-1.41%$153.65UHS-0.06%$141.17
Snapshot
Index-P/E-EPS (ttm)-0.30
Insider Own-
Shs Outstand-
Perf Week-1.97%
Market Cap1.24BForward P/E21.83EPS next Y0.41Insider Trans-Shs Float-Perf Month24.41%
Enterprise Value1.24BPEG0.73EPS next Q0.07Inst Own-Short Float-Perf Quarter7.30%
Income-22231521.00P/S1.31EPS this Y136.02%Inst Trans-Short Ratio-Perf Half Y61.62%
Sales945.92MP/B5.42EPS next Y280.24%ROA-4.06%Short Interest-Perf YTD72.83%
Book/sh-P/C24.71EPS next 5Y110.93%ROE-9.20%52W High10.69 -16.09%Perf Year139.84%
Cash/sh-P/FCF31.95EPS past 3/5Y-ROIC10.17%52W Low3.13 186.58%Perf 3Y-
Dividend Est.-EV/EBITDA284.80Sales past 3/5Y6.90% 8.54%Gross Margin20.75%Volatility3.62% 3.32%Perf 5Y-
Dividend TTM-EV/Sales1.31EPS Y/Y TTM131.25%Oper. Margin3.91%ATR (14)0.43Perf 10Y-
Dividend Ex-Date-Quick Ratio1.03Sales Y/Y TTM23.82%Profit Margin-2.35%RSI (14)66.31Recom3.25
Dividend Gr. 3/5Y-Current Ratio1.03EPS Q/Q180.00%SMA2013.01%Beta1.32Target Price6.80
Payout0.00%Debt/Eq0.41Sales Q/Q15.60%SMA5013.54%Rel Volume3.33Prev Close9.15
Employees2,350LT Debt/Eq0.33EarningsSep 15SMA20036.03%Avg Volume297.90KPrice8.97
IPO DateMar 04, 2021Option/ShortYes / YesEPS/Sales Surpr.100.00% 5.26%Net Debt/EBITDA-0.39Volume990,532Change-1.97%
Analyst Ratings
DateActionAnalystRatingTarget
Dec-17-24DowngradeJP MorganNeutral → Underweight
Feb-08-23ReiteratedJP MorganNeutral$8.00
Nov-23-22ReiteratedGoldman SachsNeutral$8.00
Nov-16-22ReiteratedCitigroupNeutral$8.00
Sep-15-22ReiteratedBarclaysEqual Weight$5.00
May-16-22DowngradeBairdOutperform → Neutral
Apr-20-22DowngradePiper SandlerNeutral → Underweight$5.00
Dec-28-21DowngradeGoldman SachsBuy → Neutral
Dec-27-21DowngradeBarclaysOverweight → Equal Weight
Sep-29-21DowngradeCitigroupBuy → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
6/30/2025
FY 2024
6/30/2024
FY 2023
6/30/2023
FY 2022
6/30/2022
FY 2021
6/30/2021
FY 2020
6/30/2020
FY 2019
6/30/2019
Total Revenue946854764
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A750269632
Gross Profit196585132
Selling, General and Administrative Excl. Other204150136
Research and Development
000
Other Operating Expense-4546519
Operating Income37-30-23
Interest Expense454
Unusual Expense
———
Non-Operating Income (Expense)53-14-5
Net Income Before Taxes-21-34-22
Income Taxes111
Consolidated Net Income-21-30-21
Net Income From Continuing Operations-21-35-23
Net Income-21-30-21
EPS (Recurring)-0.30-0.22-0.16
EPS (Basic, Before Extraordinaries)-0.30-0.22-0.16
EPS (Diluted)-0.30-0.22-0.16
EBITDA431
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.290.58—
Gross Margin20.7268.5017.28
Operating Margin3.91-3.51-3.01
Net Margin-2.22-3.51-2.75
Shares Outstanding136135136
Market Capitalization1,220498—
Operating Lease Expense
———
Insider Trading Volume
$9.90$9.23$8.56$7.90$7.23● Close Price0.00K40.42K80.85K121.28K161.70KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SCARBROUGH MICHAEL ANTHONYPresident and COONov 14 '25Sale4.9033,000161,700119,617Nov 17 12:00 AM
ZORETIC RICHARD CDirectorMay 30 '25Buy4.088,45034,47668,494May 30 12:00 AM
ZORETIC RICHARD CDirectorMay 29 '25Buy4.0414,26557,63160,044May 30 12:00 AM
ZORETIC RICHARD CDirectorMay 28 '25Buy4.0620,00081,20045,779May 30 12:00 AM
ZORETIC RICHARD CDirectorMay 23 '25Buy3.931,1984,70825,779May 23 12:00 AM
ZORETIC RICHARD CDirectorMay 22 '25Buy4.097002,86324,581May 23 12:00 AM
ZORETIC RICHARD CDirectorMay 21 '25Buy4.131,1474,73723,881May 23 12:00 AM
ZORETIC RICHARD CDirectorMay 20 '25Buy4.208073,38922,734May 20 12:00 AM
ZORETIC RICHARD CDirectorMay 16 '25Buy4.282,0868,92821,927May 20 12:00 AM
SCARBROUGH MICHAEL ANTHONYPresident and COOMay 13 '25Buy3.8910,00038,90033,000May 13 12:00 AM
SCARBROUGH MICHAEL ANTHONYPresident and COOMay 12 '25Buy3.7313,00048,49023,000May 13 12:00 AM
SCARBROUGH MICHAEL ANTHONYPresident and COOMay 09 '25Buy3.5510,00035,50010,000May 13 12:00 AM
DAMATO NICOLECHIEF LEGAL OFFICERNov 06 '24Sale6.541,66010,856231,614Nov 08 12:00 AM
DAMATO NICOLEChief Legal OfficerSep 17 '24Sale6.007,52145,126233,274Sep 18 12:00 AM
DAMATO NICOLEChief Legal OfficerSep 16 '24Sale5.954,37226,013240,795Sep 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR